Table 3.
Percent change from the filtered air exposure for individual end points per 100 µg/m3 of CAP.
| FO (n = 16) | OO (n = 13) | |||||||
|---|---|---|---|---|---|---|---|---|
| End points | Post-CAP | Follow-up | Post-CAP | Follow-up | ||||
| HRV | ||||||||
| nLF | –2.62 ± 1.85 | –0.74 ± 2.02 | 7.41 ± 2.38* | 5.47 ± 2.60* | ||||
| HF/LF | 3.67 ± 2.42 | 1.89 ± 2.77 | –7.87 ± 3.12* | –2.97 ± 3.58 | ||||
| QT | ||||||||
| QTc | 0.05 ± 0.11 | 0.08 ± 0.20 | 0.12 ± 0.15 | 0.58 ± 0.26* | ||||
| QTp | 0.22 ± 0.33 | 0.23 ± 0.43 | 0.44 ± 0.42 | 1.70 ± 0.55* | ||||
| Tp-Te | 0.65 ± 0.34 | 1.17 ± 0.48* | –0.48 ± 0.44 | 1.13 ± 0.62 | ||||
| Tp-Te/QT | 0.32 ± 0.43 | 0.72 ± 0.46 | –0.66 ± 0.56 | –0.44 ± 0.59 | ||||
| Lipids | ||||||||
| VLDL | 1.54 ± 1.95 | –5.22 ± 2.97 | 7.68 ± 2.55* | 6.33 ± 3.82 | ||||
| LDL | –0.30 ± 0.81 | 1.08 ± 0.89 | 0.54 ± 1.05 | –1.40 ± 1.15 | ||||
| HDL | –0.19 ± 0.72 | 0.59 ± 0.68 | –0.46 ± 0.93 | –1.10 ± 0.87 | ||||
| Triglycerides | 1.27 ± 1.93 | –5.32 ± 2.96 | 7.40 ± 2.52* | 6.00 ± 3.81 | ||||
| Total cholesterol | 0.13 ± 0.50 | 0.45 ± 0.61 | 1.10 ± 0.65 | –0.57 ± 0.79 | ||||
| Blood cells | ||||||||
| WBC | 0.01 ± 1.04 | 2.81 ± 1.42 | 0.06 ± 1.36 | –2.06 ± 1.83 | ||||
| RBC | –0.35 ± 0.38 | 0.21 ± 0.43 | –0.12 ± 0.49 | –0.75 ± 0.55 | ||||
| Platelets | 0.26 ± 0.48 | 0.59 ± 0.69 | –0.41 ± 0.62 | –0.30 ± 0.88 | ||||
| Neutrophils | –0.47 ± 0.91 | –0.02 ± 1.17 | –1.10 ± 1.18 | –3.05 ± 1.50* | ||||
| Lymphocytes | 0.35 ± 1.42 | –0.83 ± 2.39 | 1.27 ± 1.85 | 4.47 ± 3.08 | ||||
| Monocytes | –0.94 ± 3.12 | 1.02 ± 1.99 | 0.60 ± 4.02 | 3.13 ± 2.56 | ||||
| Parameter estimates are summarized as mean ± SE. *p < 0.05, compared to filtered air. | ||||||||